Cara Therapeutics (CARA)

Feb 20, 2025, 5:25 PM EST - 2 days ago

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA

Dec 27, 2024, 7:00 AM EST - 2 months ago

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split

Dec 18, 2024, 7:00 AM EST - 2 months ago

Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement

Jun 13, 2024, 12:21 PM EDT - 9 months ago

These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'

Jun 12, 2024, 4:19 PM EDT - 9 months ago

Cara Therapeutics discontinues study on a neurological condition as drug fails

Jun 12, 2024, 4:01 PM EDT - 9 months ago

Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica

May 13, 2024, 4:01 PM EDT - 10 months ago

Cara Therapeutics Reports First Quarter 2024 Financial Results

May 6, 2024, 7:00 AM EDT - 10 months ago

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024

Apr 2, 2024, 9:02 AM EDT - 11 months ago

Cara Therapeutics, Inc. (CARA) to Present at the 23rd Annual Needham Virtual Healthcare Conference

Apr 2, 2024, 7:00 AM EDT - 11 months ago

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 7:00 AM EST - 1 year ago

Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

Mar 4, 2024, 7:07 PM EST - 1 year ago

Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 4:01 PM EST - 1 year ago

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 12, 2024, 4:01 PM EST - 1 year ago

Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

Jan 22, 2024, 7:00 AM EST - 1 year ago

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

Dec 18, 2023, 7:00 AM EST - 1 year ago

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Nov 13, 2023, 7:20 PM EST - 1 year ago

Cara Therapeutics, Inc. (Cara) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:01 PM EST - 1 year ago

Cara Therapeutics Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

Oct 23, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023

Sep 25, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients

Aug 7, 2023, 6:13 PM EDT - 1 year ago

Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:01 PM EDT - 1 year ago

Cara Therapeutics Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors

Aug 2, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 24, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023

Jul 14, 2023, 5:11 PM EDT - 1 year ago

Cara Therapeutics Faces Uncertainty Despite Potential Reimbursement Extension For Korsuva

Jun 1, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Present at the Jefferies Healthcare Conference

May 18, 2023, 2:00 AM EDT - 1 year ago

Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

May 15, 2023, 7:31 PM EDT - 1 year ago

Cara Therapeutics, Inc. (CARA) Q1 2023 Earnings Call Transcript

May 15, 2023, 4:01 PM EDT - 1 year ago

Cara Therapeutics Reports First Quarter 2023 Financial Results

May 1, 2023, 9:20 AM EDT - 1 year ago

Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2023 Financial Results on May 15, 2023

May 1, 2023, 7:00 AM EDT - 1 year ago

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

Apr 10, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

Mar 14, 2023, 8:02 AM EDT - 2 years ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)

AHCO OPRX TKNO

Mar 14, 2023, 7:00 AM EDT - 2 years ago

Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report

Mar 13, 2023, 9:00 AM EDT - 2 years ago

Cara Therapeutics: Looking To Place A Bid After A Big Miss On Earnings

Mar 7, 2023, 10:13 AM EST - 2 years ago

Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss

Mar 6, 2023, 8:44 PM EST - 2 years ago

Cara Therapeutics, Inc. (CARA) Q4 2022 Earnings Call Transcript

Mar 6, 2023, 4:01 PM EST - 2 years ago

Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

Feb 21, 2023, 7:00 AM EST - 2 years ago

Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Feb 8, 2023, 5:00 PM EST - 2 years ago

Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

Jan 17, 2023, 7:00 AM EST - 2 years ago

Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023

Jan 3, 2023, 7:00 AM EST - 2 years ago

Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference

Dec 29, 2022, 11:15 AM EST - 2 years ago

Cannabis REITs: Smoked Out

ACB AFCG BYND CGC CNBS CRON CWEB

Nov 7, 2022, 8:31 PM EST - 2 years ago

Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call Transcript

Nov 7, 2022, 4:01 PM EST - 2 years ago

Cara Therapeutics Reports Third Quarter 2022 Financial Results

Nov 2, 2022, 7:00 AM EDT - 2 years ago

Cara Therapeutics to Present at Upcoming Investor Conferences